Literature DB >> 833986

Testis tumors associated with congenital adrenal hyperplasia: a continuing diagnostic and therapeutic dilemma.

M E Newell, B M Lippe, R M Ehrlich.   

Abstract

A 9-year-old boy with documented congenital adrenal hyperplasia owing to a deficiency in C21 hydroxylation is described. Precocious virilization and testicular asymmetry were noted when he was 5 years old. Both of these conditions persisted despite progressively larger doses of replacement steroid therapy. The right testis was 3 times larger than the left testis and serum testosterone was well within the adult male range. A right inguinal orchiectomy was performed. Pathologic diagnosis was interstitial cell tumor. A review of the literature emphasizes the continuing dilemma of separating interstitial cell tumors from hypertrophy of adrenal rest tissue in the presence of congenital adrenal hyperplasia. Possible methods of distinction are discussed.

Entities:  

Mesh:

Year:  1977        PMID: 833986     DOI: 10.1016/s0022-5347(17)58421-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Testicular adrenal-like tissue (TALT) in congenital adrenal hyperplasia: detection by ultrasonography.

Authors:  U Willi; M Atares; A Prader; M Zachmann
Journal:  Pediatr Radiol       Date:  1991

2.  Testis sparing surgery for steroid unresponsive testicular tumors of the congenital adrenal hyperplasia.

Authors:  Tuğrul Tiryaki; Zehra Aycan; Sema Hücümenoğlu; Halil Atayurt
Journal:  Pediatr Surg Int       Date:  2005-10-21       Impact factor: 1.827

3.  A patient with refractory testicular adrenal rest tumour in the setting of cyp11b1 deficiency congenital adrenal hyperplasia.

Authors:  Mohammad Reza Mirzaei; Hassan Rezvanian; Mansour Siavash; Mahmoud Parham; Parvin Mahzouni
Journal:  BMJ Case Rep       Date:  2009-04-14

Review 4.  Bilateral testicular enlargement due to adrenal remnant in a patient with C11 hydroxylase deficiency congenital adrenal hyperplasia.

Authors:  A A M Ghazi; F Hadayegh; G Khakpour; F Azizi; J C Melby
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.